Search research articles
Contact Us
Filters
Showing results (821-830 of 1,132) with videos related to
Page
of 114
Sort By:
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
July 11, 2019
Extramammary Paget Disease of the Scrotum: A Contemporary Clinicopathologic Analysis of 20 Cases in the United States
Maryam Shabihkhani, Pallavi Patil, Belkiss Murati Amador, et al.
Histopathology
|
October 10, 2019
SATB2 protein expression by immunohistochemistry is a sensitive and specific marker of appendiceal and rectosigmoid well differentiated neuroendocrine tumours
Deepthi Hoskoppal, Jonathan I Epstein, Allen M Gown, et al.
Analytical and Quantitative Cytology and Histology
|
January 9, 2001
Neural network prediction of prostate tissue composition based on magnetic resonance imaging analysis. A pilot study
I Simon, P B Snow, L S Marks, et al.
Urology
|
February 1, 1997
Prostate-specific antigen in men born with bladder exstrophy
R I Silver, A W Partin, J I Epstein, et al.
Bulletin of Experimental Biology and Medicine
|
September 2, 2003
Cytogenetic effects of antibodies to gamma-interferon in ultralow doses
O L Voronova, O P Rogozina, A V Martyushev, et al.
The Journal of Urology
|
July 1, 1992
Correlation of prostate cancer nuclear deoxyribonucleic acid, size, shape and Gleason grade with pathological stage at radical prostatectomy
J I Epstein, G Pizov, G D Steinberg, et al.
Journal of the National Cancer Institute
|
November 2, 2006
Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability
H Ballentine Carter, Luigi Ferrucci, Anna Kettermann, et al.
The Journal of Urology
|
July 4, 2006
Pathological outcomes and biochemical progression in men with T1c prostate cancer undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/ml
Danil V Makarov, Elizabeth B Humphreys, Leslie A Mangold, et al.
European Urology
|
October 13, 2015
Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery
Jeffrey J Tosoian, Debasish Sundi, Bruce J Trock, et al.
Bulletin of Experimental Biology and Medicine
|
October 16, 2015
Effects of Impaza on the Generative Function of Female Rats
E B Lavrova, L I Bugaeva, E A Kuzubova, et al.
Page
of 114
Search research articles
Search
Showing results (821-830 of 1,132) with videos related to
Sort By:
Page
of 114
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
July 11, 2019
Extramammary Paget Disease of the Scrotum: A Contemporary Clinicopathologic Analysis of 20 Cases in the United States
Maryam Shabihkhani, Pallavi Patil, Belkiss Murati Amador, et al.
Histopathology
|
October 10, 2019
SATB2 protein expression by immunohistochemistry is a sensitive and specific marker of appendiceal and rectosigmoid well differentiated neuroendocrine tumours
Deepthi Hoskoppal, Jonathan I Epstein, Allen M Gown, et al.
Analytical and Quantitative Cytology and Histology
|
January 9, 2001
Neural network prediction of prostate tissue composition based on magnetic resonance imaging analysis. A pilot study
I Simon, P B Snow, L S Marks, et al.
Urology
|
February 1, 1997
Prostate-specific antigen in men born with bladder exstrophy
R I Silver, A W Partin, J I Epstein, et al.
Bulletin of Experimental Biology and Medicine
|
September 2, 2003
Cytogenetic effects of antibodies to gamma-interferon in ultralow doses
O L Voronova, O P Rogozina, A V Martyushev, et al.
The Journal of Urology
|
July 1, 1992
Correlation of prostate cancer nuclear deoxyribonucleic acid, size, shape and Gleason grade with pathological stage at radical prostatectomy
J I Epstein, G Pizov, G D Steinberg, et al.
Journal of the National Cancer Institute
|
November 2, 2006
Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability
H Ballentine Carter, Luigi Ferrucci, Anna Kettermann, et al.
The Journal of Urology
|
July 4, 2006
Pathological outcomes and biochemical progression in men with T1c prostate cancer undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/ml
Danil V Makarov, Elizabeth B Humphreys, Leslie A Mangold, et al.
European Urology
|
October 13, 2015
Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery
Jeffrey J Tosoian, Debasish Sundi, Bruce J Trock, et al.
Bulletin of Experimental Biology and Medicine
|
October 16, 2015
Effects of Impaza on the Generative Function of Female Rats
E B Lavrova, L I Bugaeva, E A Kuzubova, et al.
Page
of 114